Dovre Group PLCOMXHEX: DOV1V

Dovre Group Plc (in debt restructuring proceedings) has sold its remaining operating subsidiaries, and the Dovre Group has been dissolved

· Issued by Dovre Group PLC

Summary by 6ix AI

Dovre Group Plc, which is in debt restructuring proceedings, sold all shares of its subsidiaries Renetec Oy and Proha Oy, and its 19.86 per cent stake in the Singaporean company Sararasa Bioindo Pte. Ltd, to Navdata Oy for cash as part of those proceedings. At the same time, the group led by Dovre was dissolved.

Key details

  • The aggregate cash purchase price for the subsidiaries and the stake is EUR 615,000.
  • Dovre no longer has any subsidiaries or associated companies engaged in operational business.
  • Dovre reiterates its earlier view of May 21, 2026 that, after the debt restructuring proceedings conclude, a merger with an entity meeting the listing requirements of Nasdaq Helsinki Oy may be regarded as an alternative serving Dovre's interests.
  • Dovre says its stated condition for continuing as a listed company, that its current assets be realised during the debt restructuring proceedings or under a restructuring programme to be confirmed by the District Court, has now been fulfilled in practice.

What’s still pending

  • Dovre remains in debt restructuring proceedings.
  • A possible merger with an entity meeting Nasdaq Helsinki Oy listing requirements is only described as an alternative that may serve Dovre's interests after the proceedings conclude.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/dovre-group-plc-in-debt-restructuring-proceedings-has-sold-its-remaining-operating-subsidiaries-and-the-dovre-group-has-been-dissolved

Dovre Group Plc | Stock Exchange Release | 1.9.2026 at 6:00 PM

Dovre Group Plc (in debt restructuring proceedings) has sold its remaining operating subsidiaries, and the Dovre Group has been dissolved

As part of the debt restructuring proceedings, Dovre Group Oyj (”Dovre”) has sold, for cash and with full ownership rights, the entire share capital of its subsidiaries Renetec Oy and Proha Oy, as well as its ownership interest in the Singaporean company Sararasa Bioindo Pte. Ltd (19.86 per cent of the share capital), to Navdata Oy.

At the same time, the group led by Dovre has been dissolved. Dovre no longer has any subsidiaries or associated companies engaged in operational business.

The aggregate cash purchase price is EUR 615,000.

Dovre reiterates the view expressed in its release published on 21.5.2026. An arrangement in which, following the conclusion of the debt restructuring proceedings, an entity meeting the listing requirements of Nasdaq Helsinki Oy would merge with Dovre may be regarded as an alternative serving Dovre’s interests.

The important condition communicated by Dovre for Dovre’s continuation as a listed company, namely that the Company’s current assets be realised either during the debt restructuring proceedings or pursuant to the provisions of a restructuring programme to be confirmed by the District Court, has now been fulfilled in practice.

Additional information
Dovre Group Plc
Kalervo Rötsä, Chairman of the Board
Tel. 040 560 9891
[email protected]

Dovre Group Plc
Markku Taskinen, CEO
Tel. 050 343 14 82
[email protected]

Distribution
Nasdaq Helsinki
Key media outlets
www.dovregroup.com

© Modular Finance, source Nordic Press Releases

Dovre Group PLC on 6ix

Earlier from Dovre

All Dovre news releases